|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Apr―13 |
Efficacy of Favipiravir and Remdesivir in the Treatment of Hospitalized Covid-19 Patients in Basrah, Iraq |
Ahmed H Al-Darraji |
2 |
[GO] |
2023―Apr―13 |
Tucaresol: A Unique Oral Candidate Drug Ideally Accessible for Treatment of Covid-19 Disease |
Christopher L. Penney, Boulos Zacharie, Jean-Simon Duceppe |
3 |
[GO] |
2022―Nov―28 |
SARS-CoV-2: Recent Past and Present: An Unusual Review |
Joseph Kajima Mulengi |
4 |
[GO] |
2022―Jul―07 |
Covid-19 and Flavonoids: In silico Molecular Dynamics Docking to the Active Catalytic Site of SARS-CoV and SARS-CoV-2 Main Protease |
Leif E. Peterson |
5 |
[GO] |
2022―Jul―07 |
Covid-19 Pandemic and Human Behavioral Response |
Fatik Baran Mandal |
6 |
[GO] |
2021―Nov―26 |
In Silico Molecular Dynamics Docking of Drugs to the Inhibitory Active Site of SARS-CoV-2 Protease and Their Predicted Toxicology and ADME |
Leif E. Peterson |